Evaluation and Management of Hypoactive Sexual Desire Disorder

por Clayton, Anita H., Kingsberg, Sheryl A., Goldstein, Irwin
Publicado 2018

Clinical role of brexpiprazole in depression and schizophrenia

por Parikh, Nishant B, Robinson, Diana M, Clayton, Anita H
Publicado 2017

Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial

por Clayton, Anita H., Gommoll, Carl, Chen, Dalei, Nunez, Rene, Mathews, Maju
Publicado 2015

Effect of Brexpiprazole on Prolactin and Sexual Functioning: An Analysis of Short- and Long-Term Study Data in Major Depressive Disorder

por Clayton, Anita H., Ivkovic, Jelena, Chen, Dalei, George, Vinu, Hobart, Mary
Publicado 2020

Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin

por Simon, James A., Clayton, Anita H., Kim, Noel N., Patel, Sejal
Publicado 2022

Characterizing sexual function in patients with generalized anxiety disorder: a pooled analysis of three vilazodone studies

por Clayton, Anita H, Durgam, Suresh, Tang, Xiongwen, Chen, Changzheng, Ruth, Adam, Gommoll, Carl
Publicado 2016

Safety and Tolerability of Evening Ethanol Consumption and Bedtime Administration of Flibanserin in Healthy Premenopausal Female Subjects

por Millheiser, Leah, Clayton, Anita H., Parish, Sharon J., Kingsberg, Sheryl A., Kim, Noel N., Simon, James A.
Publicado 2019

Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study

por Clayton, Anita H., Durgam, Suresh, Li, Dayong, Chen, Changzheng, Chen, Laishun, Mathews, Maju, Gommoll, Carl P., Szegedi, Armin
Publicado 2017

Response to Commentary by Spielmans

por Simon, James A., Clayton, Anita H., Goldstein, Irwin, Kingsberg, Sheryl A., Shapiro, Marla, Patel, Sejal, Kim, Noel N.
Publicado 2022

Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder

por Simon, James A., Clayton, Anita H., Goldstein, Irwin, Kingsberg, Sheryl A., Shapiro, Marla, Patel, Sejal, Kim, Noel N.
Publicado 2022

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials

por Kingsberg, Sheryl A., Clayton, Anita H., Portman, David, Williams, Laura A., Krop, Julie, Jordan, Robert, Lucas, Johna, Simon, James A.
Publicado 2019

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder

por Simon, James A., Kingsberg, Sheryl A., Portman, David, Williams, Laura A., Krop, Julie, Jordan, Robert, Lucas, Johna, Clayton, Anita H.
Publicado 2019

Prevalence of Substance Misuse in New Patients in an Outpatient Psychiatry Clinic Using a Prescription Monitoring Program

por Sowa, Elle M., Fellers, Jonathan C., Raisinghani, Rachna S., Santa Cruz, Maria R., Hidalgo, Priscilla C., Lee, Meredith S., Martinez, Lady A., Keller, Adrienne E., Clayton, Anita H.
Publicado 2014

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning...

por Clayton, Anita H, Baker, Ross A, Sheehan, John J, Cain, Zachary J, Forbes, Robert A, Marler, Sabrina Vogel, Marcus, Ronald, Berman, Robert M, Thase, Michael E
Publicado 2014

Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial

por Clayton, Anita H, Althof, Stanley E, Kingsberg, Sheryl, DeRogatis, Leonard R, Kroll, Robin, Goldstein, Irwin, Kaminetsky, Jed, Spana, Carl, Lucas, Johna, Jordan, Robert, Portman, David J
Publicado 2016